Shares of Oracle (ORCL) rose about 4% on Wednesday after Oppenheimer upgraded the stock to Outperform from Perform.

Investors continue to fret whether the company has bitten off more than it can chew with its AI-spending commitments.

An Oppenheimer analyst has turned bullish on Oracle’s stock after a selloff that has wiped away more than half the company’s value since its September peak.

Dozens of hospitals have had their patient data compromised by a 2025 breach of Oracle Health’s legacy Cerner systems. Health systems continue to alert patients of the hack that occurred as early as ...

Shares in Oracle, one of the world’s largest computing infrastructure companies, fell by 29.4% in the month to 13 November, as concerns over the feasibility of artificial intelligence (AI) spending ...

Netflix co-CEO Sarandos to visit White House to discuss Warner Bros bid, Politico reports Netflix co-CEO Ted Sarandos will attend meetings at the White House on Thursday to discuss the streaming giant ...

Oppenheimer & Co upgrades Oracle stock to Outperform and issues a $185 price target in a research note Wednesday.

The ABL90 FLEX PLUS delivers lab-quality results at the point of care for more confident treatment decisions. Continuous automatic quality management (AQM) provides automatic quality control, ...

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It ...